| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $7.65 ▲ +1.59% | Yesterday | $7.48 ▼ -0.67% | Tomorrow's Fulcrum Therapeutics Inc. Common Stock (FULC) setup is anchored to $7.53 and targets $7.65 (+1.59%). The near-term read is upside; watch $7.76 / $7.30 because daily realized volatility is about 8.00%. |
Tomorrow's Fulcrum Therapeutics Inc. Common Stock (FULC) setup is anchored to $7.53 and targets $7.65 (+1.59%). The near-term read is upside; watch $7.76 / $7.30 because daily realized volatility is about 8.00%. | ||||
| Week | $7.90 ▲ +4.95% | Last Week | $7.37 ▼ -2.08% | The 7-day Fulcrum Therapeutics Inc. Common Stock model moves from $7.37 to $7.90 (+4.95%). It gives upside momentum context for this stock, so breaks around $7.76 / $7.30 matter more than a single tick. |
The 7-day Fulcrum Therapeutics Inc. Common Stock model moves from $7.37 to $7.90 (+4.95%). It gives upside momentum context for this stock, so breaks around $7.76 / $7.30 matter more than a single tick. | ||||
| Month | $8.32 ▲ +10.54% | Last Month | $7.20 ▼ -4.43% | The 1-month Fulcrum Therapeutics Inc. Common Stock target is $8.32 (+10.54%), compared with the live reference near $7.53. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Fulcrum Therapeutics Inc. Common Stock target is $8.32 (+10.54%), compared with the live reference near $7.53. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $8.96 ▲ +18.93% | Last Year | $6.93 ▼ -7.95% | The 1-year Fulcrum Therapeutics Inc. Common Stock scenario points to $8.96 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Fulcrum Therapeutics Inc. Common Stock scenario points to $8.96 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $10.43 ▲ +38.57% | 5 Years Ago | $6.31 ▼ -16.20% | The 5-year Fulcrum Therapeutics Inc. Common Stock view is $10.43 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Fulcrum Therapeutics Inc. Common Stock view is $10.43 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $7.53 | Mid |
| Daily Change | -5.16% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $7.53 | Daily Change | -5.16% |
| Market Cap | $501.50M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.